Abstract
Our aim was to review the processes of glutamate release from both biochemical and neurophysiological points of view. A large body of evidence now indicates that glutamate is specifically accumulated into synaptic vesicles, which provides strong support for the concept that glutamate is released from synaptic vesicles and is the major excitatory neurotransmitter. Evidence suggests the notion that synaptic vesicles, in order to sustain the neurotransmitter pool of glutamate, are endowed with an efficient mechanism for vesicular filling of glutamate. Glutamate-loaded vesicles undergo removal of Synapsin I by CaM kinase II-mediated phosphorylation, transforming to the release-ready pool. Vesicle docking to and fusion with the presynaptic plasma membrane are thought to be mediated by the SNARE complex. The Ca2+-dependent step in exocytosis is proposed to be mediated by synaptotagmin.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Synaptic Transmissions and Quantal Theory
Our review focuses on release of glutamate from presynaptic terminals in the vertebrate CNS, in crustacean neuromuscular junctions, and the squid giant synapse. Biochemical, structural and functional properties are considered. A summary of the development of the synaptic concept provides a technical background and historical perspective.
Early Morphological, Pharmacological, and Physiological Evidence for Synapses
Ramon y Cajal [1] used Golgi’s silver staining technique to visualize microscopically the entire structure of individual neurons. Cajal described such structures as the dendritic tree and traced the course of axons to their contacts on target neurons. Many of his drawings used arrows to illustrate how neurons integrated synaptic information (e.g.: Parallel fiber and climbing fiber inputs to Purkinje cell, Fig. 104, p 121).
Sherrington [2] furthered the concept of neuron theory by suggesting that the direction of impulse traffic was regulated at the neuronal contact for which he coined the term “SYNAPSE” from the Greek word meaning to clasp. The implication was that there was a functional contact between nerve cells for the transmission of nerve impulses from one neuron to another.
Loewi [3] demonstrated that acetylcholine was released from the vagus nerve innervating the heart. However, the possibility that chemical neurotransmission occurred in the brain was rejected early in favor of electrotonic transmission primarily because of the apparent short synaptic latency. Eccles [4] resolved this issue in favor of chemical neurotransmission. A schematic summary of presynaptic and postsynaptic processes characteristic of all chemical synapses is provided in Fig. 1.
Physiological Evidence for Packaged Neurotransmitter
Katz et al. [5, 6], using recently developed microelectrodes [7], penetrated frog muscle fibers and recorded millivolt signals in the region of motor nerve terminals (end-plates). These small, spontaneously occurring potentials were named miniature end-plate potentials (mepp’s) because they were similar in shape to the end-plate potentials (epp’s) evoked by action potentials in the presynaptic nerve. Both epp’s and mepp’s decreased in amplitude as the recording microelectrode was placed further from the end-plate region.
Their amplitude also decreased following application of curare to block the postsynaptic receptors and conversely increased by applying blockers of acetylcholine esterase. Moreover, extracellular calcium ion (Ca2+) concentration (below 2 mM) decreased the amplitude of the epp’s but not the mepp’s. Similarly, repetitive presynaptic nerve stimulation resulted in a decrease in the amplitude of epp’s but not mepp’s. These observations led to the concept that the presynaptic action potential evoked a postsynaptic response that was made up of hundreds of smaller events which Katz called quanta. The quantal size was not reduced by most treatments. However, it was later shown that hemicholinium-3 did reduce the amplitude of mepp’s but only after repetitive simulation [8]. This was explained as a decrease in amount of acetylcholine stored per quanta following the block of choline uptake into the presynaptic nerve terminal, which was necessary for acetylcholine synthesis.
Quantal release has also been detected as stepwise changes in capacitance [9] and small current changes measured with etched carbon-fiber microelectrodes [10]. Combining these techniques has allowed the detection of incomplete vesicular fusion known as kiss-and-run exocytosis (for review, see Ref. [11]).
Electron Microscopy of Presynaptic Vesicles
About the time Katz recorded mepp’s, anatomists using the electron microscope found vesicles in presynaptic terminals in the CNS [12–14]. This led to the concept that the “quanta” were the result of a fixed amount of neurotransmitter stored in “presynaptic vesicles”. The quantal theory of Katz stated that vesicles are the storage site of transmitter that was released either spontaneously or by presynaptic action potentials. The released neurotransmitter crossed a synaptic cleft before activating their specific receptors in the postsynaptic membrane.
Excitatory Actions of Acidic Amino Acids
The majority of excitatory synapses in the brain are not mediated by acetylcholine, serotonin, or norepinephrine. A large number of acidic amino acids have been electrophoretically injected onto neurons in the brain and have produced strong excitation [21–24]. There is a similarity between the depolarizing action produced by amino acids and the depolarizing action of excitatory synapse. An example is shown in the frog cerebellum where glutamate was compared with EPSPs of climbing and parallel fibers [25].
Difficulty in Acceptance of Glutamate as a Neurotransmitter
Despite the pharmacological evidence suggesting a neurotransmitter role for glutamate, many were initially skeptical that glutamate could function as a natural neurotransmitter. There were three major reasons, the first teleological. Glutamate occurs as a major biochemical, not just in neurons, but in all cells in the entire biological system. As such, glutamate is involved in a number of other important cellular processes, such as energy and nitrogen metabolism and the synthesis of proteins, peptides, nucleic acids, and folic acid, as well as the inhibitory neurotransmitter GABA. In contrast, all the other well recognized neurotransmitters (acetylcholine, GABA, norepinephrine, dopamine, and serotonin) are synthesized only in neurons and some endocrine cells, and function solely as neurotransmitters or hormones.
Second, although Curtis et al. [21] clearly demonstrated rapid, reversible, and potent effects of glutamate in evoking neuronal firing in the majority of CNS neurons, they concluded, based upon its apparent non-specific action, that glutamate does not serve as a neurotransmitter. It had been thought that neurotransmitters act only on specific neurons, based upon similar observations with all other classical neurotransmitters.
Third, evidence was lacking at the time for accumulation of glutamate in synaptic vesicles. Studies by Mangan and Whittaker [26], Rassin [27], and Kontro et al. [28] showed that glutamate was not enriched in isolated synaptic vesicles. Likewise, there was no evidence that synaptic vesicles are capable of concentrating glutamate [29]. Based on this and other evidence, it was proposed that glutamate is released from the cytosol, rather than from the synaptic vesicle [30]. This failed to provide support for the notion that glutamate functions as a neurotransmitter; well-established neurotransmitters had been found concentrated in synaptic vesicles.
Release of Glutamate
Ca2+ -dependent release is an important criterion for a substance to be considered a candidate for neurotransmitter. De Belleroche and Bradford [31] showed that high K+- or veratrine-induced depolarization of synaptosomes (from cerebral cortex) caused release of glutamate. Sandoval et al. [32] provided evidence for Ca2+ dependent, high K+-induced release of glutamate from hippocampal synaptosomes. Hamberger et al. [33] also provided evidence for Ca2+-dependent glutamate release using a hippocampus slice preparation. However, in all cases it was concluded that the release originated from the cytosol. Subsequently, Nicholls and Sihra [34] and Tibbs et al. [35] clearly demonstrated that depolarization-induced endogenous glutamate release from synaptosomes (from cerebral cortex) occurs rapidly in a Ca2+-dependent manner, originating most likely from synaptic vesicles (for review, see Ref. [36]).
Evidence for Accumulation of Glutamate in Synaptic Vesicles
Critical for synaptic transmission is the uptake of glutamate into synaptic vesicles. Clear biochemical demonstration of vesicular neurotransmitter loading requires preparation of synaptic vesicles free of contamination with other intracellular organelles and plasma membranes. Naito and Ueda [16] isolated synaptic vesicles using antibodies specific to Synapsin I [37], a synaptic vesicle-specific protein [38–41]. These vesicles were free from other organelles and plasma membranes, and demonstrated to take up glutamate in an ATP-dependent manner. ATP-dependent glutamate uptake into synaptic vesicles was shown to be driven by an electrochemical proton gradient, specific to glutamate and markedly stimulated by low millimollar Cl− [42]. Disbrow et al. [43] also reported ATP-dependent glutamate uptake into crude and partially purified synaptic vesicles. However, the ATP stimulation was marginal. This is most likely the result of two factors: Cl concentration (see below) and organelle and other sealed membrane contaminants. Moreover, specificity to glutamate was not addressed. Neither ATP nor low millimolar Cl− was included in the incubation medium by previous investigators [29]. The presence of low millimolar Cl− as well as ATP in the incubation medium, not to mention the use of a highly purified synaptic vesicle preparation, proved critical for clear demonstration of glutamate accumulation into synaptic vesicles [16, 42].
Storm-Mathisen et al. [44] provided immunocytochemical evidence for glutamate accumulation in synaptic vesicles, distinct from GABA containing synaptic vesicles. Maycox et al. [45] also showed that highly purified synaptic vesicles by chromatography on controlled-pore glass beads take up glutamate at the expense of an electrochemical gradient. Moreover, Burger et al. [46] demonstrated that glutamate is concentrated in rapidly isolated synaptic vesicles. Of interest, glutamate accumulated into synaptic vesicles was not well maintained in the absence of an electrical proton gradient [47]. This could explain, at least in part, the initial failure to demonstrate enrichment of glutamate in isolated synaptic vesicles [26–28]. These lines of evidence together provided strong support for the concept that glutamate has a neurotransmitter function.
ATP energy is harnessed by vesicle-bound proton-pump ATPase to generate an electrochemical proton gradient, which provides the driving force for the vesicular glutamate transporter [16, 42, 45, 48–65]. This vesicular uptake system is not only specific to glutamate, but also unique in sensitivity to Cl− [42]. Thus, the vesicular glutamate transporter, VGLUT, does not recognize aspartate [42, 49, 50, 52, 54–60, 63, 66–69]. Of particular interest, the vesicular glutamate uptake system is stimulated by low concentrations and inhibited by high concentrations of Cl−.
This unique property was initially observed by Naito and Ueda [42], and is now well established [48–50, 52–54, 56–58, 60, 62–66, 70, 71]. Moreover, affinity for glutamate is low [42, 49, 50, 52–54, 56–60, 63]. At physiologically relevant Cl− concentrations, both the membrane potential and the pH gradient contribute to the driving force [42, 51, 53, 56, 64]. These properties render VGLUT distinct from the plasma membrane glutamate transporter [72]. The latter utilizes the sodium gradient as the driving force, does not distinguish between glutamate and aspartate, is not subject to bimodal chloride modulation, and has high affinity for glutamate [73, 74]. VGLUT’s low affinity for glutamate is compatible with high cytosolic concentrations of glutamate, whereas the plasma membrane transporter requires high affinity for glutamate, since the extracellular concentration of glutamate is maintained at very low levels. These observations led to the model that the vesicular glutamate uptake system consists of proton-pump ATPase and a vesicular glutamate transporter [54, 65, 72, 75–77].
Mechanism of Bimodal Modulation by Cl− of Vesicular Glutamate Transport
Low millimolar Cl− concentrations increase Vmax with little change in Km for glutamate, whereas further increase in Cl− concentrations reduces Vmax and increases Km for glutamate [42, 53]. The inhibitory effect of high Cl− concentrations is attenuated by high glutamate concentrations [42, 53, 64]. The Cl− stimulation was ascribed to an optimal pH (around 6.8) created in the vesicle lumen, due to low influx of Cl− [51]. This pH may be optimal for activating VGLUT, possibly by facilitating release of translocated yet bound glutamate. Hartinger and Jahn [78] and Juge et al. [63, 70] have provided evidence suggesting that that the Cl− stimulation occurs due to activation of VGLUT by binding to an external regulatory site.
On the other hand, Schenk et al. [64] have provided evidence suggesting that VGLUT1 has membrane potential-driven Cl− transport function, and causes glutamate flux by a membrane potential-dependent Cl−/glutamate antiporter mechanism, ruling out the possibility that Cl− binds to a regulatory site of VGLUT1. Chloride conductance by VGLUT1 had also been shown by Bellocchio et al. [56]. VGLUT1 was also proposed to act as a proton/glutamate antiporter, which is thought to be the sole mechanism when Cl− is absent in the vesicle lumen [64]. The proton/glutamate antiporter model for vesicular glutamate transport was also previously proposed [79].
Thus, in the presence of Cl− in the vesicle lumen, membrane potential alone can transport glutamate into synaptic vesicles, whereas in its absence, glutamate transport does not occur even in the presence of membrane potential. When a low concentration of Cl− is present in the extravesicular medium, a Cl− influx-induced pH gradient is formed, which allows glutamate influx. The contribution of the pH gradient is greater when Cl− is absent in the lumen [64]. In the absence of intravesicular Cl−, the pH gradient dependency of glutamate uptake is higher when extravesicular glutamate concentration is lower, suggesting that glutamate and Cl− compete for transport into vesicles. This was also suggested by Bellocchio et al. [56]. Thus, higher Cl− concentration inhibits glutamate uptake into vesicles. This explanation for high Cl−-induced, lowered vesicular glutamate uptake is in agreement with the notion that Cl− interacts with the glutamate binding site of VGLUT [42].
In contrast, Juge et al. [63] have ascribed the high Cl−-induced inhibition of vesicular glutamate uptake to collapse of the driving force membrane potential, due to an increase in pH gradient. However, under conditions in which the membrane potential was enhanced by nigericin (K+/H+ exchanger) or A23187 (Ca2+ or Mg2+/H+ exchanger) and maintained constantly high in the presence of various concentrations of Cl−, Cl−-dependent suppression of vesicular glutamate was still observed [51, 53]. In agreement with observations by Hartinger et al. [78], studies by Juge et al. [63, 70] suggest that low Cl− activates VGLUT2 by binding to an allosteric site. VGLUT2 did not cause Cl− transport into liposomes devoid of proton-pump ATPase when the membrane potential was generated by valinomycin.
However, when proton-pump ATPase is present in liposomes, low Cl−-stimulated glutamate uptake (as well as high Cl−-suppressed glutamate uptake) via VGLUT1 is substantially reduced by dissipating the pH gradient [64]. Thus, the mechanism underlying the Cl− bimodal modulation remains controversial. Mention may be made, however, that intact synaptic vesicles are endowed with proton-pump ATPase. Hence, although the membrane potential alone can cause glutamate transport into vesicles, membrane potential-driven Cl− influx would also occur under physiological conditions, resulting in formation of a pH gradient which could, in addition, significantly contribute to the driving force [42, 51, 53, 56, 64].
Under physiological conditions, synaptic vesicles would contain some Cl− in the lumen and be surrounded by a low millimolar cytosolic concentration of Cl−. In this situation, according to the model proposed by Schenk et al. [64], glutamate transport into synaptic vesicles would occur by both the membrane potential-dependent Cl−/glutamate exchange and proton/glutamate symport mechanisms. The membrane potential is thought to play a role in changing the conformation of VGLUT. This is supported by observations suggesting that the membrane potential alters the affinity of VGLUT for glutamate; the Km value for glutamate is increased by dissipating the membrane potential [18, Lee and Ueda, unpublished data] and decreased by increasing the membrane potential [53] in the absence or presence of low millimolar Cl−. When synaptic vesicles are exposed to non-physiological, high concentrations of Cl−, vesicular glutamate uptake is reduced. This could be partly due to reduced Cl− efflux, resulting in reduced glutamate influx, and partly due to competition between glutamate and Cl− for the vesicular entry site of VGLUT [42, 53, 54, 64]. Evidence indicates that glutamate uptake Vmax is reduced by high concentrations of Cl−, compared to that at low millimolar Cl−, whereas Km for glutamate is increased [42, 53].
Recently, Preobraschenski et al. [80] presented evidence that Cl− translocation is an intrinsic property of VGLUT, but not coupled to glutamate transport. Thus, high Cl− concentrations can reduce vesicular glutamate by competing for the glutamate transport site. The former property is consistent with observations by Bellocchio et al. [56] and Schenk et al. [64], but the latter contradicts the notion that VGLUT mediates Cl−/glutamate exchange [53, 64]. It is proposed that the stimulatory effect of low millimolar Cl− is due to VGLUT activation by binding to an allosteric site in agreement with Hartinger et al. [78] and Juge et al. [63, 70]. The apparent discrepancy between the observations of Schenk et al. [64] and Preobraschenski et al. [80] and those of Juge et al. [70], with respect to the ability of VGLUT to mediate Cl− flux, could be due to the difference in lipid composition of the proteoliposomes used. Liposomes used by Schenk et al. [64] and Preobraschenski et al. [80] consisted of phospholipid mixtures, whereas those used by Juge et al. [70] contained basically a single phospholipid component, phosphatidylcholine. It is feasible that phospholipid composition could affect transport function. Glutamate uptake activity in proteoliposomes composed of a phospholipid mixture [64] was much higher than in proteoliposomes comprised of a phosphatidylcholine only [70]. Carlson et al. [26] had also shown that a phospholipid mixture, not a single phospholipid, is required for optimal ATP-dependent glutamate uptake activity in a reconstituted system.
Vesicular Glutamate Transporter
The vesicular glutamate transporter protein had eluded identification for some time. In 2000, Takamori et al. [55] and Bellocchio et al. [56] demonstrated that a brain specific-isoform of the sodium-dependent inorganic phosphate transporter [81] functions as VGLUT. This was soon followed by identification of two additional isoforms, VGLUT2 [57–60, 67, 68, 82] and VGLUT3 [61, 62, 83, 84]. These isoforms differ largely in N- and C-terminal domains, but exhibit similar uptake characteristics [57–60, 62, 67, 83, 84]. They belong to the SLC 17 family [65]. In general, they have complementary distributions in the adult brain. However, in some glutamatergic nerve terminals and certain endocrine cells, as well as at early developmental stages, VGLUT1 and VGLUT2 are colocalized [85–92, 96]. VGLUT1 and VGLUT2 expression levels have been demonstrated to control quantal size [93–95]. VGLUT3 is peculiar in that it is expressed in dendrites, astrocytes and non-nervous tissues as well as in nerve terminals [84, 86, 96–98]. These observations suggest their involvement in different synaptic functions. VGLUT1 has been suggested to have a role in modulating transmitter release probability and synaptic plasticity, as well as in the reserved pool of vesicles [57, 60, 86, 87, 99, 100]. Colocalization of VGLUT 3 and vesicular acetylcholine and monoamine transporters has been implicated in motor control, reward behavior, and neuropsychiatric disease [84]. Subsequent studies indicate that all VGLUTs are colocalized with subsets of vesicular GABA and acetylcholine transporters. VGLUT2 is present in additional subsets of vesicles containing dopamine and norepinephrine, and VGLUT3 in an additional subset of serotonin-containing vesicles (for review, see Ref. [101]). Thus, VGLUT expression levels can modulate the vesicle’s capacity to accumulate these transmitters. This co-phenotype has behavioral implications.
Energy Source Required for Vesicular Glutamate Uptake
Synaptic transmission depends on glycolysis [102], which generates the smaller pool of ATP. Global cellular ATP levels are hardly changed under those hypoglycemic conditions which cause initial abnormal synaptic transmission [103, 104]. Substitution with pyruvate, the final product of glycolysis, which feeds into mitochondria, producing the majority of ATP, does not restore normal synaptic transmission [102], even though tissue levels of ATP return to normal [103]. Fleck et al. [105] showed that hypoglycemic conditions which reduce glutamate release did not significantly alter cellular ATP content. These observations raised the possibility that a glycolytic intermediate or a minor pool of ATP locally synthesized might play a critical role in glutamate release. Ikemoto et al. [106] have provided evidence suggesting that glycolytically generated ATP, rather than mitochondrial ATP, plays a major role in providing energy for vesicular glutamate accumulation. The glyceroaldehyde-3-phosphate dehydrogenase (GAPDH) inhibitor iodoacetate suppressed glutamate accumulation into vesicles, whereas the mitochondrial ATP-synthetase inhibitor oligomycin had minimal effects. These observations are compatible with the finding by Shepherd and Harris [107] that approximately 50 % of hippocampal CA3/CA1 nerve terminals are devoid of mitochondria.
Of importance, synaptic vesicles were found to be endowed with the glycolytic ATP-generating enzyme complex, GAPDH/3-phosphoglycerate kinase, which is harnessed to generate energy for immediate active transport of glutamate into synaptic vesicles [106], consistent with proteomic studies [108–110]. Evidence suggests that a sub-population of synaptic vesicles bear pyruvate kinase, which is also capable of supporting vesicular glutamate uptake [111]. These observations together support the notion that locally synthesized glycolytic ATP is the major energy source harnessed for efficiently refilling of synaptic vesicles with glutamate [112]. It is interesting to note that the vital role of local synthesis of glycolytic ATP in fast axonal transport of synaptic vesicles has also been demonstrated recently [113].
Precursor for VGLUT Substrate
In eukaryotes, glutamate is synthesized by three enzymes:
-
(a)
amino acid aminotransferase
-
(b)
glutamate dehydrogenase
-
(c)
glutaminase
Which enzyme or enzymes are responsible for formation of the neurotransmitter pool of glutamate remains to be fully elucidated. Glutamine is widely thought to be the principal precursor for synthesis of the neurotransmitter glutamate. Bradford et al. [114] and Hamberger et al. [33], using brain synaptosomes and hippocampal slices, respectively, incubated with radioactive glutamine and glucose, provided biochemical evidence that glutamine is the major substrate for the neurotransmitter pool of glutamate. This, together with specific localization of glutamine synthetase in astrocytes [115] and glutaminase enrichment in synaptosomes, particularly in mitochondria therein [116], as well as the notion of the glutamate–glutamine cycle [117, 118], has led to the concept that the glutamate–glutamine cycle plays a central role in supplying a precursor for synthesis of the neurotransmitter glutamate [119–121]. According to this model, released glutamate from nerve terminals is largely taken up by astrocytes, where it is converted to glutamine, which is then transported out to the extracellular space. The released glutamine is taken up by neurons and converted back to glutamate by glutaminase in mitochondria. Glutamate thus produced and released from mitochondria had been thought to be utilized as the neurotransmitter glutamate.
In support of this notion is evidence that phosphate-activated glutaminase is localized to the exterior of the inner mitochondrial membrane [122, 123]. However, other evidence indicates that the active site of this enzyme is on the matrix side of the mitochondrial inner membrane [124–128]. Indeed Palaiologos et al. [129] provided evidence suggesting that glutamate produced from glutamine is transformed to α-ketoglutarate by aspartate aminotransferase (AAT) in mitochondria [130] and exported to the cytoplasm, mediated by the dicarboxylic acid exchanger [131, 132]. α-Ketoglutarate released from mitochondria was then converted to glutamate, which is released in a Ca2+-dependent manner. Glutamate was assumed to be resynthesized by AAT in the cytosol [129, 133].
Takeda et al. [134] have demonstrated that isolated synaptic vesicles are capable of synthesizing glutamate from α-ketoglutarate and l-aspartate (as the specific amino donor) by vesicle-bound AAT for immediate uptake. Glutamine was not an effective substrate for glutamate synthesis, consistent with the vesicle’s deficiency in glutaminase. These observations suggest local synthesis of the neurotransmitter pool of glutamate at the synaptic vesicle, an efficient mechanism for vesicular glutamate refilling and, hence, glutamate transmission. Vesicle-bound AAT belongs to the mitochondrial type (GOT2) based upon kinetic and immunological properties [134] and proteomics analyses [109, 110]. Vesicle-bound AAT has much higher affinity for aspartate than does the cytosolic isozyme (GOT1). The aspartate Km of the former is substantially lower than its cellular concentrations, whereas that of the latter is significantly higher. This suggests that vesicle-bound AAT would function at close to Vmax. These findings indicate that α-ketoglutarate can effectively serve as an immediate precursor for synthesis of the neurotransmitter glutamate. Thus, vesicle-bound AAT could represent an efficient mechanism for generating the vesicular pool of glutamate.
α-Ketoglutarate would be derived from neuronal mitochondria, where it is produced from glutamine-derived glutamate [129] or from glucose via the TCA cycle, or could be supplied from astrocytes [135], where de novo synthesis of α-ketoglutarate occurs via CO2 fixation of pyruvate, followed by the TCA cycle [136–145]. Synaptosomes have been shown to be capable of taking up α-ketoglutarate [146–148, Takeda and Ueda, unpublished observations] as well as glutamine [114; Takeda and Ueda, unpublished observations].
Since the catalytic site of mitochondrial glutaminase is likely to be localized to the inner surface of the mitochondrial inner membrane [124–128], the glutamine–glutamate conversion would occur in the matrix, where glutamate, rather than directly released to the cytoplasm, is largely transformed to α-ketoglutarate by mitochondrial AAT [129, 133] and glutamate dehydrogenase [149–152]. A large part of α-ketoglutarate produced from glutamine and a small part of α-ketoglutarate from glucose could be transferred to the cytoplasm, as mentioned above. These lines of evidence taken together suggest that α-ketoglutarate, not glutamine, serves as the major immediate precursor for the neurotransmitter pool of glutamate. However, in view of immunocytochemical evidence suggesting that cytosolic AAT is associated with glutamatergic nerve terminals [153, 154], the relative contribution of vesicle-bound versus cytosolic AAT to synthesis of the neurotransmitter pool of glutamate remains to be established.
Although the glutamate–glutamine cycle is thought by many to play the central role in supplying the precursor of the neurotransmitter glutamate, the synthesis of the glutamate responsible for spontaneous synaptic transmission remains less clear [77]. Kam and Nicoll [155] showed that vesicular release of glutamate from neurons in culture devoid of astrocytes occurs even in the absence of glutamine in the culture medium. Masson et al. [156] observed that genetic deletion of phosphate-activated glutaminase partially reduced but did not abolish evoked release, whereas it had little effect on spontaneous release of glutamate. These lines of evidence indicate that the glutamate–glutamine cycle may not play the exclusive role in providing the immediate precursor for synthesis of the neurotransmitter pool of glutamate, in particular that released spontaneously and responsible for generating the miniature excitatory postsynaptic current. This suggests alternative pathways for such a role. α-Ketoglutarate derived from glucose or some amino acids or odd chain fatty acids [145] via the TCA cycle could serve as such a precursor. Glutamate could also be formed from some amino acids [145]. Moreover, it is plausible that even the synthesis of vesicular glutamate derived from glutamine could well be mediated in large part by formation of α-ketoglutarate, as described above. A proposed effective mechanism for synthesis and vesicular loading of the neurotransmitter glutamate is shown in Fig. 2.
Glutamate Release Regulation Via Modulation of VGLUT Activity and Expression
Since VGLUT plays a pivotal role in glutamate synaptic transmission, it is likely to be subject to regulation. This regulation would be important in controlling neuronal communication. A number of VGLUT inhibitors have been reported [52, 62, 70, 94, 157–170, 172]. However, only three inhibitors have been shown capable of down-regulating the amount of exocytotically released glutamate: the vesicular transmitter uptake inhibitory protein factor (IPF) [164], Rose Bengal [165], and ketone bodies, in particular acetoacetic acid [70]. IPF is a potent VGLUT inhibitor with a high molecular weight and an elongated shape [160]. When incorporated into synaptosomes, it led to reduction of exocytotically released glutamate [164]. However, the physiological function of IPF is not known. Rose Bengal is also a potent VGLUT inhibitor and, being hydrophobic in nature, permeates the synaptosome plasma membrane. Thus, it was shown able to suppress the amount of glutamate released by exocytosis [165]. However, both IPF and Rose Bngal exhibited potent inhibition of vesicular uptake of GABA and serotonin as well [160, 164, 167, 171]. Thus, these agents proved non-specific to VGLUT.
Recently, Rose Bengal has been reported to attenuate glutamate synaptic transmission [173, 174]. However, the effective concentrations were much higher than in glutamate release [165]. Juge et al. [70] have shown that ketone bodies inhibit VGLUT2 by blocking Cl− activation, and that acetoacetate, the most potent, is capable of abolishing depolarization-induced glutamate release at millimollar concentrations. Acetoacetate decreased not only the amplitude and but also the frequency of occurrence of mEPSCs. These ketone bodies were suggested responsible for the benefits of the ketogenic diet on controlling seizures [70]. Other α-keto acids found in the maple syrup urine disorder, such as α-keto-β-methyl-n-methyl valeric acid and α-ketoisocaproic acid, have also been reported to inhibit vesicular glutamate uptake by blocking the Cl−-activating site [175]. However, these agents appear to also compete with the glutamate transport site. All the VGLUT-inhibitory keto acids reported are endogenous substances, but not potent. The most potent, highly VGLUT-specific inhibitors known today are Trypan Blue [161] and Brilliant Yellow [172], but these are not membrane-permeable. Thus, membrane-permeable, potent VGLUT-specific inhibitors, which could specifically regulate glutamate release, remain to be developed.
Characteristics of Three Glutamatergic Synapses
There are many synapses for which glutamate acts as the transmitter. Of these we have selected three which have other important values including their physiology, pharmacology, and recent molecular biology. Evidence for glutamate as the transmitter at squid, crayfish, and mammalian CNS synapses is widely acknowledged. Briefly included here are some examples of acceptable evidence. The localization and content of glutamate in the giant synapse of squid [176] constitutes some of the strongest evidence. This is in the face of problems involving experiments with glutamate application to neurons, determining the glutamate reversal potential, and detecting release of glutamate. In crayfish muscle, the distribution and pharmacological properties of synaptic glutamate receptors provide strong support for glutamatergic synaptic transmission [177]. It is well accepted that the vast majority of fast synaptic responses in the vertebrate brain use glutamate.
Presynaptic Ca2+
An important property of synapses is the requirement of Ca2+ for evoked release as first demonstrated at the frog neuromuscular junction [178, 179]. In early observations on squid giant axons, Katz further demonstrated the importance of Ca2+ where strong depolarization of nerve terminals resulted in reduced transmission as the membrane potential reached the equilibrium potential for Ca2+ [180, 181]. Direct measurement of intracellular increase in Ca2+ was first shown in presynaptic terminals of the squid giant synapse with the Ca2+ detecting protein, aequorin [182]. Llinas et al. [183] used voltage clamp that characterized presynaptic Ca2+ currents and was able to demonstrate a minimal synaptic delay of 200 µs between a rapid influx of Ca2+ and the beginning of the postsynaptic response.
A classification scheme for Ca2+ channels (N-, T-, and L-types) was first described for sensory neurons [184] and then sympathetic neurons [185]. Interestingly, the N-type Ca2+ channels are coupled to norepinephrine release from the sympathetic neurons [186]. For most hippocampus glutamatergic neurons N-type [187] and P/Q-type [188, 189] Ca2+ channels contribute to synaptic transmission. The pharmacology of P-type Ca2+ channels indicates the release of glutamate at the squid giant synapse [190] and at the crayfish neuromuscular junction [191].
Ca2+ Dependence
Synaptic transmission requires Ca2+ for action potential evoked release [178] but not for spontaneous release [192, 193]. The Ca2+ appeared necessary to couple the action potential to the release process, but the final steps leading to exocytosis did not require Ca2+.
The synaptic vesicle protein, synaptotagmin, in combination with RIM, Rim BP and Munc 13 have been hypothesized to be involved in Ca2+-dependent release of neurotransmitter [194–196]. Synaptotagmin null mutants fail to have rapid synchronous neurosecretion but still respond to α-latrotoxin [195, 196].
Scheme of Synapsin Function
The role of Synapsin I in neurotransmitter (NT) release is well established and reviewed by Greengard et al. [200]. The hypothetical scheme of Synapsin I function is shown in Fig. 3. Synaptic vesicles (SV) are normally in a resting condition surrounded by bound Synapsin I. Synapsin I is also bound to F-actin, tethering synaptic vesicles to actin filaments and rendering the vesicles unavailable for release. Depolarization of the nerve terminal triggers an influx of Ca2+ and the activation of the calcium/calmodulin dependent protein kinase II (CaM-PK II). Phosphorylation (P) of Synapsin I by CaM-PK II decreases its affinity for the synaptic vesicles. The denuded vesicle can now be mobilized into a releasable pool. Activation of the vesicle by Ca2+ and other factors results in exocytosis and the release of neurotransmitter. The cycle is completed by the formation of new vesicles that are replenished with transmitter and recoated with dephospho-Synapsin I [201, 202].
SNARE Proteins
The SNARE hypothesis [194, 197–199] states that the presynaptic vesicle acts as a donor or agonist for a target molecular complex in the nerve terminal membrane (see Table 1). The docking and subsequent fusion events are thought to be mediated by the interaction of a protein complex consisting of cyctosolic proteins (SNAPs and NSF) with 3 synaptic proteins SNAP-25, Synaptobrevin and Syntaxin (the SNARE proteins). Munc 18 is a Syntaxin associated protein which acts to “clamp” the complex. Complexin binds to this partially assembled SNARE complex, generating the “superprimed” state. The v-SNARE Synaptobrevin is in the synaptic vesicle membrane while Syntaxin and SNAP-25 (t-SNARES) are in the presynaptic plasma membrane. The protein complex that recruits Ca2+ channels to active zones involves RIM, RIM-binding protein, and Munc 13 (a priming factor) interacting with Synaptotagmin. Ca2+ binding to synaptotagmin enables synaptotagmin to displace part of complexin bound to the SNARE complex, as well as to interact with plasma membrane phospholipid. This triggers vesicle-plasma membrane fusion pore opening, allowing initial neurotransmitter release, followed by complete membrane fusion. Thus, synaptotagmin mediates rapid coupling of action potential-induced Ca2+ influx to transmitter release.
In support of this hypothesis, injection of recombinant SNAPs into the giant presynaptic terminal of the squid enhances transmitter release [203]. Conversely, injection of peptides designed to mimic the sites at which SNAPs interacts with its binding partners inhibits transmitter release.
The Visualization of Vesicles in Living Preparations with Total Internal Reflectance Microscopy
First shown with exocytosis from chromaffin cells, Steyer et al. [204] used Total Internal Reflectance Fluorescence (TIRF) microscopy to demonstrate that dense core vesicles about 250 nm in diameter approach (24 nm/s, top speed 114 nm/s) and fuse with the plasma membrane (0.8 sites/μm2). The technique relies on a laser beam that is directed at the interface between a glass coverslip and overlying solution at an angle that results in total reflectance of the beam back into the glass. An evanescent layer develops in the solution about 200 nm above the coverslip. The technique circumvents the resolution limits of bright field optics (200 nm). In both chromaffin cells and bipolar neurons [204, 205] repetitive stimulation results in reduced neurosecretion (fewer released vesicles).
Synaptic Plasticity: Persistent and Cumulative Neurotransmitter Release
Chemical synaptic transmission is not a static process. The release of neurotransmitter may increase or decrease depending upon the past history of the presynaptic activity. The examples given here are in well studied glutamatergic synapses: crustacean neuromuscular junction, squid giant synapse, and hippocampal synapses.
Short Term Synaptic Plasticity
-
1.
Depression can be explained simply as a loss of the presynaptic vesicular store of neurotransmitter following repetitive stimulation. Also, depression can be reversed by rest.
-
2.
Facilitation of neurosecretion elicited by repetitive stimuli is characterized by an early phase and a late phase. This is true of frog neuromuscular junction [206], squid giant synapses [207], and crayfish neuromuscular junctions [208–210].
Frequency facilitation is a process whereby the quantal content increases as a function of repetitive stimulation. Analysis of the frequency dependence of the presynaptic parameters n (number of quanta capable of responding to a nerve impulse) and P (average probability of responding) has revealed the physiological basis underlying facilitation. Recent evidence suggests that the amount of glutamate per vesicle could alter P [211]. Since both n and P increase as a function of frequency, facilitation has been described in terms of the rates of quantal mobilization and demobilization [212, 213].
Facilitation requires Ca2+ influx into the presynaptic terminal [214], and they proposed that facilitation at the neuromuscular junction is due to a residue of Ca2+ that enters during nerve stimulation. Strong support for the residual calcium theory came from experiments in which intracellular calcium was reduced by photolabile Ca2+ [215].
-
3.
A more complete description of persistent effects was given by Magelby [216] in which enhanced release included facilitation as well as augmentation and potentiation (see Table 2). These forms of persistent neurosecretion were also dependent on residual Ca2+ [215]. Moreover, these different forms of release appear to require Ca2+ at different sites. The molecular mechanisms of how and where Ca2+ acts are still unresolved.
Synaptic Plasticity: Long-Term Persistent and Cumulative Release
-
1.
Long term facilitation (LTF) at crustacean neuromuscular junctions is independent of Na+ or Ca2+ currents in presynaptic terminals. Experiments in which an inhibitor of adenylate cyclase was injected into nerve terminals blocked LTF [217]. Nerve impulses are somehow coupled to adenylate cyclase and the generation of cAMP which in turn activates protein kinase A and the enhancement of synaptic transmission.
-
2.
The discovery of hippocampal long term potentiation (LTP) by Bliss and Lomo [218] is significant. Previously Ramon y Cajal [1] suggested that learning and memory could take place at synapses in the brain. Stimulation of a specific pathway at high frequency can cause an increase in synaptic strength that lasts over 10 h. In a search for sites and mechanisms of action, differential effects were obtained, dependent on the particular pathway activated [219]. Repetitive activation of the mossy fiber input to CA3 pyramidal cells will cause LTP without postsynaptic depolarization. Stimulation of other pathways (Schaffer collateral fibers, commissural fibers, and perforant path fibers) evoke LTP but only with concurrent depolarization of the postsynaptic neuron. The postsynaptic action involves released glutamate which activates both AMPA and NMDA receptors [219]. Current initially flows through the AMPA receptors but not through NMDA receptors because those receptor channels are blocked by Mg. Depolarization of the postsynaptic neuron removes the Mg block of the NMDA receptor and allows Na+ and Ca+ to enter the cell. Some aspects of LTP may be due to retrograde action back to the presynaptic glutamatergic terminals [219].
-
3.
Long term depression occurs at cortical and cerebellar excitatory synapses. Similar to LTP, LTD involves postsynaptic elevation of intracellular calcium.
Astrocytic Release of Glutamate
Although the focus of this review is on the release of glutamate from nerve terminals, it is interesting that considerable effort has been placed on the release of glutamate from astrocytes. There are many properties of glutamate release from astrocytes that are similar to what is discussed above and it should be added that many of these are controversial [220]. It appears too early to discount these findings, but their function related to neurons is rather difficult to understand in terms of time [155] and space. Neuronal signaling relies on fast and precise timing as well as intricate and detailed anatomy. Perhaps astrocytic function will have a broad effect yet to be established.
Conclusion
Preparation for excitatory synaptic transmission in the vertebrate brain and spinal cord begins with transmitter synthesis and loading into synaptic vesicles. A large body of evidence now indicates that glutamate is specifically accumulated into synaptic vesicles, mediated by VGLUT at the expense of an electrochemical proton gradient generated by vesicular proton-pump ATPase. This provides strong support for the concept that glutamate is released from synaptic vesicles and plays a major role as an excitatory neurotransmitter.
Evidence suggests that vesicle-bound ATPase largely harnesses ATP generated via glycolysis, particularly by vesicle-bound GAPDH/3-phosphoglycerate kinase and pyruvate kinase. Other evidence suggests that synaptic vesicles are also capable of synthesizing glutamate by vesicle-bound AAT (of the mitochondrial type, distinct from the cytosolic isozyme) from α-ketoglutarate and aspartate. Both α-ketoglutarate and aspartate would be derived largely from mitochondria in the nerve terminal. α-Ketoglutarate synthesized de novo via pyruvate carboxylation could also be supplied from adjacent astrocytes. The majority of α-ketoglutarate originating in the mitochondria would be generated from glutamine-derived glutamate. Some may be a glucose-derived TCA cycle product.
These observations support the notion that synaptic vesicles, in order to sustain the neurotransmitter pool of glutamate, are endowed with an efficient mechanism for vesicular filling of glutamate. A proposed mechanism for synthesis of the neurotransmitter pool of glutamate is shown above in Fig. 2. However, in view of the occurrence of glycolytic ATP-generating enzymes and AAT in the cytosol, the relative contribution of the vesicle-bound versus cytosolic enzymes remains to be determined. Also to be developed are membrane-permeable, potent VGLUT-specific inhibitory agents, which could regulate glutamate release and synaptic transmission.
Glutamate-loaded vesicles undergo removal of Synapsin I by CaM kinase II-mediated phosphorylation, transforming to the release-ready pool. Vesicle docking to and fusion with the presynaptic plasma membrane are thought to be mediated by the SNARE complex. The Ca2+-dependent step in exocytosis is proposed to be mediated by synaptotagmin.
Our aim was to review the processes of glutamate release from both biochemical and neurophysiological points of view. The accumulation of this knowledge has the benefit of providing a basis for understanding important mechanisms in space and time.
Abbreviations
- AAT:
-
Aspartate aminotransferase
- CNS:
-
Central nervous system
- CaM-PK:
-
Calmodulin-dependent protein kinase
- GABA:
-
γ-Aminobutyric acid
- mepp:
-
Miniature end-plate potential
- RIM:
-
Rab3 interacting molecule
- RIM-BP:
-
RIM-binding protein
- SNARE:
-
Soluble N-ethylmaleimide-sensitive factor attachment protein receptor
- TCA:
-
Tricarboxylic acid
- VGLUT:
-
Vesicular glutamate transporter
References
Ramon y Cajal S (1995) Histology of the nervous system, vol 2. Oxford University Press, p 121
Sherrington CS (1897) The central nervous system. In: Foster M (ed) A textbook of physiology, vol 3. MacMillan, London
Loewi O (1921) Uber humorale ubertragbarkeit der Herznervenwirkung. Pflugers Arch Physiolog 189:239–242
Eccles JC (1964) The physiology of synapses. Springer, Berlin-Gottingen-Heidelberg
Fatt P, Katz B (1950) Some observations on biological noise. Nature 166:597–598
Del Castillo J, Katz B (1954) Quantal components of the endplate potential. J Physiol 124:560–573
Ling G, Gerard RW (1949) The normal membrane potential of frog sartorius fibers. J. Cell Comp Physiol 34:383–396
Elmqvist D, Quastel DMJ (1965) Presynaptic action of hemicholinium at the neuromuscular junction. J Physiol 177:463–482
Fernandez JM, Neher E, Gomperts BD (1984) Capacitance measurements reveal stepwise fusion events in degranulating mast cells. Nature 312:453–455
Wightman RM, Jankowski JA, Kennedy RT, Kawagoe KT, Schroeder TJ, Leszczyszyn DJ, Near JA, Diliberto EJ Jr, Viveros OH (1991) Temporally resolved catecholamine spikes correspond to single vesicle release from individual chromaffin cells. Proc Natl Acad Sci USA 88:10754–10758
Alabi AA, Tsien RW (2013) Perspectives on kiss-and-run: role in exocytosis, endocytosis, and neurotransmission. Annu Rev Physiol 75:393–422
De Robertis E (1956) Submicroscopic changes of the synapse after nerve section in the acoustic ganglion of the guinea pig. J Biophys Biochem Cytol 2:503–512
Gray EG (1959) Axo-somatic and axo-dendritic synapses of the cerebral cortex: and electron microscope study. J Anat 93:420–433
Whittaker VP, Gray EG (1962) The synapse: biology and morphology. Brit Med Bull 18:223–228
Whittaker VP, Michaelson IA, Kirkland RJ (1964) The separation of synaptic vesicles from nerve-ending particles (‘synaptosomes’). Biochem J 90:293
Naito S, Ueda T (1983) Adenosine triphosphate-dependent uptake of glutamate into protein I-associated synaptic vesicles. J Biol Chem 258:696–699
Fatt P, Katz B (1953) The effect of inhibitory nerve impulses on a crustacean muscle fibre. J Physiol 121:374–389
Dudel J, Orkand RK (1960) Spontaneous potential changes at crayfish neuromuscular junctions. Nature 186:476–477
Katz B, Miledi R (1963) A study of spontaneous miniature potentials in spinal motoneurones. J Physiol 168:389–422
Miledi R (1967) Spontaneous synaptic potentials and quantal release of transmitter in the stellate ganglion of the squid. J Physiol 192:379–406
Curtis DR, Phillis JW, Watkins JC (1960) The chemical excitation of spinal neurones by certain acidic amino acids. J Physiol 150:656–682
Curtis DR, Phillis JW, Watkins JC (1961) Actions of aminoacids on the isolated hemisected spinal cord of the toad. Brit J Pharmacol Chemotherapy 16:262–283
Krenjevic K, Phillis JW (1963) Actions of certain amines on cerebral cortical neurones. Brit J Pharmacol Chemotherapy 20:471–479
Curtis DR, Davis R (1963) The excitation of lateral geniculate neurones by quaternary ammonium derivatives. J Physiol 165:62–82
Hackett JT, Hou SM, Cochran SL (1979) Glutamate and synaptic depolarization of Purkinje cells evoked by parallel fibers and by climbing fibers. Brain Res 170:377–380
Mangan JL, Whittaker VP (1966) The distribution of free amino acids in subcellular fractions of guinea-pig brain. Biochem J 98:128–137
Rassin DK (1972) Amino acids as putative transmitters: failure to bind to synaptic vesicles of guinea pig cerebral cortex. J Neurochem 19:139–148
Kontro P, Marnela KM, Oja SS (1980) Free amino acids in the synaptosome and synaptic vesicle fractions of different bovine brain areas. Brain Res 184:129–141
De Belleroche JS, Bradford HF (1973) Amino acids in synaptic vesicles from mammalian cerebral cortex: a reappraisal. J Neurochem 21:441–451
De Belleroche JS, Bradford HF (1977) On the site of origin of transmitter amino acids released by depolarization of nerve terminals in vitro. J Neurochem 29:335–343
De Belleroche JS, Bradford HF (1972) Metabolism of beds of mammalian cortical synaptosomes: response to depolarizing influences. J Neurochem 19:585–602
Sandoval ME, Horch P, Cotman CW (1978) Evaluation of glutamate as a hippocampal neurotransmitter: glutamate uptake and release from synaptosomes. Brain Res 142:285–299
Hamberger AC, Chiang GH, Nylén ES, Scheff SW, Cotman CW (1979) Glutamate as a CNS transmitter. I. Evaluation of glucose and glutamine as precursors for the synthesis of preferentially released glutamate. Brain Res 168:513–530
Nicholls DG, Sihra TS (1986) Synaptosomes possess an exocytotic pool of glutamate. Nature 321:772–773
Tibbs GR, Barrie AI, Van-Mieghem F, McMahon HT, Nicholls DG (1989) Repetitive action potentials in isolated nerve terminals in the presence of 4-aminopyridine: effects on cytosolic free Ca2+ and glutamate release. J Neurochem 53:1693–1699
Nicholls DG, Attwell D (1990) The release and uptake of excitatory amino acids. Trends Pharmacol Sci 11:462–468
Naito S, Ueda T (1981) Affinity-purified anti-protein I antibody. Specific inhibitor of phosphorylation of protein I, a synaptic protein. J Biol Chem 256:10657–10663
Ueda T, Greengard P (1977) Adenosine 3′:5′-monophosphate-regulated phosphoprotein system of neuronal membranes. I. Solubilization, purification, and some properties of an endogenous phosphoprotein. J Biol Chem 252:5155–5163
Ueda T, Greengard P, Berzins K, Cohen RS, Blomberg F, Grab DJ, Siekevitz P (1979) Subcellular distribution in cerebral cortex of two proteins phosphorylated by a cAMP-dependent protein kinase. J Cell Biol 83:308–319
Bloom FE, Ueda T, Battenberg E, Greengard P (1979) Immunocytochemical localization, in synapses, of protein I, an endogenous substrate for protein kinases in mammalian brain. Proc Natl Acad Sci USA 76:5982–5986
De Camilli P, Harris SM Jr, Huttner WB, Greengard P (1983) Synapsin I (Protein I), a nerve terminal-specific phosphoprotein. II. Its specific association with synaptic vesicles demonstrated by immunocytochemistry in agarose-embedded synaptosomes. J Cell Biol 96:1355–1373
Naito S, Ueda T (1985) Characterization of glutamate uptake into synaptic vesicles. J Neurochem 44:99–109
Disbrow JK, Gershten MJ, Ruth JA (1982) Uptake of l-[3H] glutamic acid by crude and purified synaptic vesicles from rat brain. Biochem Biophys Res Commun 108:1221–1227
Storm-Mathisen J, Leknes AK, Bore AT, Vaaland JL, Edminson P, Haug E-MS, Ottersen OP (1983) First visualization of glutamate and GABA in neurons by immunocytochemistry. Nature 301:517–520
Maycox PR, Deckwerth T, Hell JW, Jahn R (1988) Glutamate uptake by brain synaptic vesicles. Energy dependence of transport and functional reconstitution in proteoliposomes. J Biol Chem 263:15423–15428
Burger PM, Mehl E, Cameron PL, Maycox PR, Baumert M, Lottspeich F, De Camilli P, Jahn R (1989) Synaptic vesicles immunoisolated from rat cerebral cortex contain high levels of glutamate. Neuron 3:715–720
Carlson MD, Ueda T (1990) Accumulated glutamate levels in the synaptic vesicle are not maintained in the absence of active transport. Neurosci Lett 110:325–330
Fykse EM, Christensen H, Fonnum F (1989) Comparison of the properties of gamma-aminobutyric acid and l-glutamate uptake into synaptic vesicles isolated from rat brain. J Neurochem 52:946–951
Carlson MD, Kish PE, Ueda T (1989) Characterization of the solubilized and reconstituted ATP-dependent vesicular glutamate uptake system. J Biol Chem 264:7369–7376
Tabb JS, Ueda T (1991) Phylogenetic studies on the synaptic vesicle glutamate transport system. J Neurosci 11:1822–1828
Tabb JS, Kish PE, Van Dyke R, Ueda T (1992) Glutamate transport into synaptic vesicles. Roles of membrane potential, pH gradient, and intravesicular pH. J Biol Chem 267:15412–15418
Moriyama Y, Yamamoto A (1995) Vesicular l-glutamate transporter in microvesicles from bovine pineal glands. J Biol Chem 270:22314–22320
Wolosker H, de Souza DO, de Meis L (1996) Regulation of glutamate transport into synaptic vesicles by chloride and proton gradient. J Biol Chem 271:11726–11731
Ozkan ED, Ueda T (1998) Glutamate transport and storage in synaptic vesicles. Jpn J Pharmacol 77:1–10
Takamori S, Rhee JS, Rosenmund C, Jahn R (2000) Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 407:189–194
Bellocchio EE, Reimer RJ, Fremeau RTJ, Edwards RH (2000) Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science 289:957–960
Fremeau RT Jr, Troyer MD, Pahner I, Nygaard GO, Tran CH, Reimer RJ, Bellocchio EE, Fortin D, Storm-Mathisen J, Edwards RH (2001) The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 31:247–260
Bai L, Xu H, Collins JF, Ghishan FK (2001) Molecular and functional analysis of a novel neuronal vesicular glutamate transporter. J Biol Chem 276:36764–36769
Herzog E, Bellenchi GC, Gras C, Bernard V, Ravassard P, Bedet C, Gasnier B, Giros B, El Mestikawy S (2001) The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons. J Neurosci 21:RC181
Varoqui H, Schafer MK-H, Zhu H, Weihe E, Erickson JD (2002) Identification of the differentiation-associated Na+/Pi transporter as a novel vesicular glutamate transporter expressed in a distinct set of glutamatergic synapses. J Neurosci 22:142–155
Takamori S, Malherbe P, Broger C, Jahn R (2002) Molecular cloning and functional characterization of human vesicular glutamate transporter 3. EMBO Rep 3:798–803
Schafer MK-H, Varoqui H, Defamie N, Weihe E, Erickson JD (2002) Molecular cloning and functional identification of mouse vesicular glutamate transporter 3 and its expression in subsets of novel excitatory neurons. J Biol Chem 277:50734–50748
Juge N, Yoshida Y, Yatsushiro S, Omote H, Moriyama Y (2006) Vesicular glutamate transporter contains two independent transport machineries. J Biol Chem 281:39499–39506
Schenck S, Wojcik SM, Brose N, Takamori S (2009) A chloride conductance in VGLUT1 underlies maximal glutamate loading into synaptic vesicles. Nat Neurosci 12:156–162
Omote H, Miyaji T, Juge N, Moriyama Y (2011) Vesicular neurotransmitter transporter: bioenergetics and regulation of glutamate transport. Biochemistry 50:5558–5565
Fischer-Bovenkerk C, Kish PE, Ueda T (1988) ATP-dependent glutamate uptake into synaptic vesicles from cerebellar mutant mice. J Neurochem 51:1054–1059
Takamori S, Rhee JS, Rosenmund C, Jahn R (2001) Identification of differentiation-associated brain-specific phosphate transporter as a second vesicular glutamate transporter (VGLUT2). J Neurosci 21:182
Hayashi M, Otsuka M, Morimoto R, Hirota S, Yatsushiro S, Takeda J, Yamamoto A, Moriyama Y (2001) Differentiation-associated Na+-dependent inorganic phosphate cotransporter (DNPI) is a vesicular glutamate transporter in endocrine glutamatergic systems. J Biol Chem 276:43400–43406
Winter HC, Ueda T (2008) The glutamate uptake system in synaptic vesicles: further characterization of structural requirements for inhibitors and substrates. Neurochem Res 33:223–231
Juge N, Gray JA, Omote H, Miyaji T, Inoue T, Hara C, Uneyama H, Edwards RH, Nicoll RA, Moriyama Y (2010) Metabolic control of vesicular glutamate transport and release. Neuron 68:99–112
Hell JW, Maycox PR, Jahn R (1990) Energy dependence and functional reconstitution of the gamma-aminobutyric acid carrier from synaptic vesicles. J Biol Chem 265:2111–2117
Ueda T (1986) Glutamate transport in the synaptic vesicle. In: Storm-Mathisen J, Bradford H (eds) Excitatory amino acids (Roberts PJ. Macmillan, London, pp 173–195
Logan WJ, Snyder SH (1972) High affinity uptake systems for glycine, glutamic and aspartic acids in synaptosomes of rat central nervous tissues. Brain Res 42:413–431
Schousboe A, Hertz L (1981) Role of astroglial cells in glutamate homeostasis. In: Di Chihara G, Gressa GL (eds) Glutamate as a neurotransmitter. Raven Press, New York, pp 103–113
Ueda T (1984) ATP-dependent uptake of glutamate into synaptic vesicles. In: Oosawa F, Yoshioka T, Hayashi H (eds) Transmembrane signaling and sensation. Japan Scientific Societies Press, Tokyo, pp 247–262
Maycox PR, Hell JW, Jahn R (1990) Amino acid neurotransmission: spotlight on synaptic vesicles. Trends Neurosci 13:83–87
Edwards RH (2007) The neurotransmitter cycle and quantal size. Neuron 55:835–858
Hartinger J, Jahn R (1993) An anion binding site that regulates the glutamate transporter of synaptic vesicles. J Biol Chem 268:23122–23127
Shioi J, Ueda T (1990) Artificially imposed electrical potentials drive l-glutamate uptake into synaptic vesicles of bovine cerebral cortex. Biochem J 267:63–68
Preobraschenski J, Zander JF, Suzuki T, Ahnert-Hilger G, Jahn R (2014) Vesicular glutamate transporters use flexible anion and cation binding sites for efficient accumulation of neurotransmitter. Neuron 84:1287–1301
Ni B, Rosteck PR Jr, Nadi NS, Paul SM (1994) Cloning and expression of a cDNA encoding a brain-specific Na(+)-dependent inorganic phosphate cotransporter. Proc Natl Acad Sci USA 91:5607–5611
Aihara Y, Mashima H, Onda H, Hisano S, Kasuya H, Hori T, Yamada S, Tomura H, Yamada Y, Inoue I, Kojima I, Takeda J (2000) Molecular cloning of a novel brain-type Na+-dependent inorganic phosphate cotransporter. J Neurochem 74:2622–2625
Gras C, Herzog E, Bellenchi GC, Bernard V, Ravassard P, Pohl M, Gasnier B, Giros B, El Mestikawy S (2002) A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J Neurosci 22:5442–5451
Fremeau RT Jr, Burman J, Qureshi T, Tran CH, Proctor J, Johnson J, Zhang H, Sulzer D, Copenhagen DR, Storm-Mathisen J, Reimer RJ, Chaudhry FA, Edwards RH (2002) The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc Natl Acad Sci USA 99:14488–14493
Morimoto R, Hayashi M, Yatsushiro S, Otsuka M, Yamamoto A, Moriyama Y (2003) Co-expression of vesicular glutamate transporters (VGLUT1 and VGLUT2) and their association with synaptic-like microvesicles in rat pinealocytes. J Neurochem 84:382–391
Fremeau RT Jr, Voglmaier S, Seal RP, Edwards RH (2004) VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci 27:98–103
Fremeau RT Jr, Kam K, Qureshi T, Johnson J, Copenhagen DR, Storm-Mathisen J, Chaudhry FA, Nicoll RA, Edwards RH (2004) Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. Science 304:1815–1819
Herzog E, Takamori S, Jahn R, Brose N, Wojcik SM (2006) Synaptic and vesicular co-localization of the glutamate transporters VGLUT1 and VGLUT2 in the mouse hippocampus. J Neurochem 99:1011–1018
Persson S, Boulland JL, Aspling M, Larsson M, Fremeau RT Jr, Edwards RH, Storm-Mathisen J, Chaudhry FA, Broman J (2006) Distribution of vesicular glutamate transporters 1 and 2 in the rat spinal cord, with a note on the spinocervical tract. J Comp Neurol 497:683–701
Brumovsky P, Watanabe M, Hökfelt T (2007) Expression of the vesicular glutamate transporters-1 and -2 in adult mouse dorsal root ganglia and spinal cord and their regulation by nerve injury. Neurosci 147:469–490
Nakamura K, Hioki H, Fujiyama F, Kaneko T (2005) Postnatal changes of vesicular glutamate transporter (VGluT)1 and VGluT2 immunoreactivities and their colocalization in the mouse forebrain. J Comp Neurol 492:263–288
Ge SN, Ma YF, Hioki H, Wei YY, Kaneko T, Mizuno N, Gao GD, Li JL (2010) Coexpression of VGLUT1 and VGLUT2 in trigeminothalamic projection neurons in the principal sensory trigeminal nucleus of the rat. J Comp Neurol 518:3149–3168
Wojcik SM, Rhee JS, Herzog E, Sigler A, Jahn R, Takamori S, Brose N, Rosenmund C (2004) An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. Proc Natl Acad Sci USA 101:7158–7163
Wilson NR, Kang J, Hueske EV, Leung T, Varoqui H, Murnick JG, Erickson JD, Liu G (2005) Presynaptic regulation of quantal size by the vesicular glutamate transporter VGLUT1. J Neurosci 25:6221–6234
Moechars D, Weston MC, Leo S, Callaerts-Vegh Z, Goris I, Daneels G, Buist A, Cik M, van der Spek P, Kass S, Meert T, D’Hooge R, Rosenmund C, Hampson RM (2006) Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain. J Neurosci 26:12055–12066
Boulland JL, Qureshi T, Seal RP, Rafiki A, Gundersen V, Bergersen LH, Fremeau RT Jr, Edwards RH, Storm-Mathisen J, Chaudhry FA (2004) Expression of the vesicular glutamate transporters during development indicates the widespread corelease of multiple neurotransmitters. J Comp Neurol 480:264–280
Ni Y, Parpura V (2009) Dual regulation of Ca2+-dependent glutamate release from astrocytes: vesicular glutamate transporters and cytosolic glutamate levels. Glia 57:1296–1305
Ormel L, Stensrud MJ, Chaudhry FA, Gundersen V (2012) A distinct set of synaptic-like microvesicles in atroglial cells contain VGLUT3. Glia 60:1289–1300
Weston MC, Nehring RB, Wojcik SM, Rosenmund C (2011) Interplay between VGLUT isoforms and endophilin A1 regulates neurotransmitter release and short-term plasticity. Neuron 69:1147–1159
Herman MA, Ackermann F, Trimbuch T, Rosenmund C (2014) Vesicular glutamate transporter expression level affects synaptic vesicle release probability at hippocampal synapses in culture. J Neurosci 34:11781–11791
El Mestikawy S, Wallén-Mackenzie A, Fortin GM, Descarries L, Trudeau LE (2011) From glutamate co-release to vesicular synergy: vesicular glutamate transporters. Nat Rev Neurosci 12:204–216
Cox DW, Bachelard HS (1982) Attenuation of evoked field potentials from dentate granule cells by low glucose, pyruvate + malate, and sodium fluoride. Brain Res 239:527–534
Cox DW, Morris PG, Feeney J, Bachelard HS (1983) 31Pn. m.r. studies on cerebral energy metabolism under conditions of hypoglycaemia and hypoxia in vitro. Biochem J 212:365–370
Bachelard HS, Cox DW, Drower J (1984) Sensitivity of guinea-pig hippocampal granule cell field potentials to hexoses in vitro: an effect on cell excitability? J Physiol 352:91–102
Fleck MW, Henze DA, Barrionuevo G, Palmer AM (1993) Aspartate and glutamate mediate excitatory synaptic transmission in area CA1 of the hippocampus. J Neurosci 13:3944–3955
Ikemoto A, Bole DG, Ueda T (2003) Glycolysis and glutamate accumulation into synaptic vesicles. Role of glyceraldehyde phosphate dehydrogenase and 3-phosphoglycerate kinase. J Biol Chem 278:5929–5940
Shepherd GMG, Harris KM (1998) Three-dimensional structure and composition of CA3-CA1 axons in rat hippocampal slices: implications for presynaptic connectivity and compartmentalization. J Neurosci 18:8300–8310
Coughenour HD, Spaulding RS, Thompson CM (2004) The synaptic vesicle proteome: a comparative study in membrane protein identification. Proteomics 4:3141–3155
Takamori S, Holt M, Stenius K, Lemke EA, Grønborg M, Riedel D, Urlaub H, Schenck S, Brügger B, Ringler P, Müller SA, Rammner B, Gräter F, Hub JS, De Groot BL, Mieskes G, Moriyama Y, Klingauf J, Grubmüller H, Heuser J, Wieland F, Jahn R (2006) molecular anatomy of a trafficking organelle. Cell 127:831–846
Burre J, Beckhaus T, Schägger H, Corvey C, Hofmann S, Karas M, Zimmermann H, Volknandt W (2006) Analysis of the synaptic vesicle proteome using three gel-based protein separation techniques. Proteomics 6:6250–6262
Ishida A, Noda Y, Ueda T (2009) Synaptic vesicle-bound pyruvate kinase can support vesicular glutamate uptake. Neurochem Res 34:807–818
Ueda T, Ikemoto A (2007) Cytoplasmic glycolytic enzymes. Synaptic vesicle-associated glycolytic ATP-generating enzymes: coupling to neurotransmitter accumulation. In: Gibson G, Dienel G (eds) Handbook neurochem. molecular neurobiology, 3rd edn, Brain energetics, cellular and molecular integration. Springer, Heidelberg, pp 241–259
Zala D, Hinckelmann MV, Yu H, Lyra da Cunha MM, Liot G, Cordelières FP, Marco S, Saudou F (2013) Vesicular glycolysis provides on-board energy for fast axonal transport. Cell 152:479–491
Bradford HF, Ward HK, Thomas AJ (1978) Glutamine—a major substrate for nerve endings. J Neurochem 30:1453–1459
Martinez-Hernandez A, Bell KP, Norenberg MD (1977) Glutamine synthetase: glial localization in brain. Science 195:1356–1358
Bradford HF, Ward HK (1976) On glutaminase activity in mammalian synaptosomes. Brain Res 110:115–125
van den Berg CJ, Garfinkel D (1971) A simulation study of brain compartments. Metabolism of glutamate and related substances in mouse brain. Biochem J 123:211–218
Benjamin AM, Quastel JH (1972) Locations of amino acids in brain slices from the rat. Biochem J 128:631–646
Cotman CW, Foster AC, Lanthorn TH (1981) An overview of glutamate as a neurotransmitter. In: Di Chiara G, Gessa GL (eds) Glutamate as a neurotransmitter. Raven Press, New York, pp 1–27
Shank RP, Aprison MH (1988) Glutamate as a neurotransmitter. In: Kvamme E (ed) Glutamine and glutamate in mammals, vol. II. CRC Press, Boca Raton, pp 3–20
Schousboe A, Westergaard N, Waagepetersen H, Larsson OM, Bakken IJ, Sonnewald U (1997) Trafficking between glia and neurons of TCA cycle intermediates and related metabolites. Glia 21:99–105
Kvamme E, Torgner IA, Roberg B (1991) Evidence indicating that pig renal phosphate-activated glutaminase has a functionally predominant external localization in the inner mitochondrial membrane. J Biol Chem 266:13185–13192
Roberg B, Torgner IA, Kvamme E (1995) The orientation of phosphate activated glutaminase in the inner mitochondrial membrane of synaptic and non-synaptic rat brain mitochondria. Neurochem Int 27:367–376
Shapiro RA, Haser WG, Curthoys NP (1985) The orientation of phosphate-dependent glutaminase on the inner membrane of rat renal mitochondria. Arch Biochem Biophys 243:1–7
Aledo JC, de Pedro E, Gomez-Fabre PM, de Castro IN, Marquez J (1997) Submitochondrial localization and membrane topography of Ehrlich ascitic tumour cell glutaminase. Biochim Biophys Acta 1323:173–184
Albrecht J, Dolinska M, Hilgier W, Lipkowski AW, Nowacki J (2000) Modulation of glutamine uptake and phosphate-activated glutaminase activity in rat brain mitochondria by amino acids and their synthetic analogues. Neurochem Int 36:341–347
Ziemińska E, Hilgier W, Waagepetersen HS, Hertz L, Sonnewald U, Schousboe A, Albrecht J (2004) Analysis of glutamine accumulation in rat brain mitochondria in the presence of a glutamine uptake inhibitor, histidine, reveals glutamine pools with a distinct access to deamidation. Neurochem Res 29:2121–2123
Bak LK, Zieminnska E, Waagepetersen HS, Schousboe A, Albrecht J (2008) Metabolism of [U-13C] glutamine and [U-13C]glutamate in isolated rat brain mitochondria suggests functional phosphate-activated glutaminase activity in matrix. Neurochem Res 33:273–278
Palaiologos G, Hertz L, Schousboe A (1988) Evidence that aspartate aminotransferase activity and ketodicarboxylate carrier function are essential for biosynthesis of transmitter glutamate. J Neurochem 51:317–320
Dennis SC, Lai JC, Clark JB (1977) Comparative studies on glutamate metabolism in synpatic and non-synaptic rat brain mitochondria. Biochem J 164:727–736
Bisaccia F, Indiveri C, Palmieri F (1985) Purification of reconstitutively active alpha-oxoglutarate carrier from pig heart mitochondria. Biochim Biophys Acta 810:362–369
Bolli R, Nałecz KA, Azzi A (1989) Monocarboxylate and alpha-ketoglutarate carriers from bovine heart mitochondria. Purification by affinity chromatography on immobilized 2-cyano-4-hydroxycinnamate. J Biol Chem 264:18024–18030
Schousboe A, Bak LK, Waagepetersen HS (2013) Astrocytic control of biosynthesis and turnover of the neurotransmitters glutamate and GABA. Front Endocrinol (Lausanne) 4:102
Takeda K, Ishida A, Takahashi K, Ueda T (2012) Synaptic vesicles are capable of synthesizing the VGLUT substrate glutamate from α-ketoglutarate for vesicular loading. J Neurochem 121:184–196
Westergaard N, Sonnewald U, Schousboe A (1994) Release of α-ketoglutarate, malate and succinate from cultured astrocytes: possible role in amino acid neurotransmitter homeostasis. Neurosci Lett 176:105–109
Patel MS (1974) The relative significance of CO -fixing enzymes in the metabolism of rat brain. J Neurochem 22:717–724
Yu AC, Drejer J, Hertz L, Schousboe A (1983) Pyruvate carboxylase activity in primary cultures of astrocytes and neurons. J Neurochem 41:1484–1487
Shank RP, Bennett GS, Freytag SO, Campbell GL (1985) Pyruvate carboxylase: astrocyte-specific enzyme implicated in the replenishment of amino acid neurotransmitter pools. Brain Res 329:364–367
Shank RP, Leo GC, Zielke HR (1993) Cerebral metabolic compartmentation as revealed by nuclear magnetic resonance analysis of D-[1-13C]glucose metabolism. J Neurochem 61:315–323
Cesar M, Hamprecht B (1995) Immunocytochemical examination of neural rat and mouse primary cultures using monoclonal antibodies raised against pyruvate carboxylase. J Neurochem 64:2312–2318
Hertz L, Peng L, Dienel GA (2007) Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J Cereb Blood Flow Metab 27:219–249
Serres S, Raffard G, Franconi JM, Merle M (2008) Close coupling between astrocytic and neuronal metabolisms to fulfill anaplerotic and energy needs in the rat brain. J Cereb Blood Flow Metab 28:712–724
Sonnewald U, Rae C (2010) Pyruvate carboxylation in different model systems studied by 13C MRS. Neurochem Res 35:1916–1921
Morken TS, Brekke E, Håberg A, Widerøe M, Brubakk AM, Sonnewald U (2014) Neuron–astrocyte interactions, pyruvate carboxylation and the pentose phosphate pathway in the neonatal rat brain. Neurochem Res 39:556–569
Sonnewald U (2014) Glutamate synthesis has to be matched by its degradation—where do all the carbons go? J Neurochem 131:399–406
Shank RP, LeM Campbell G (1981) Avid Na+-dependent high-affinity uptake of alpha-ketoglutarate by nerve terminal enriched material from mouse cerebellum. Life Sci 28:843–850
Shank RP, Campbell GL (1982) Glutamine and alpha-ketoglutarate uptake and metabolism by nerve terminals enriched material from mouse cerebellum. Neurochem Res 7:601–616
Shank RP, Campbell GL (1984) Alpha-ketoglutarate and malate uptake and metabolism by synaptosomes: further evidence for an astrocyte-to-neuron metabolic shuttle. J Neurochem 42:1153–1161
Tildon JT, Roeder LM, Stevenson JH (1985) Substrate oxidation by isolated rat brain mitochondria and synaptosomes. J Neurosci Res 14:207–215
McKenna MC, Tildon JT, Stevenson JH, Boatright R, Huang S (1993) Regulation of energy metabolism in synaptic terminals and cultured rat brain astrocytes: differences revealed using aminooxyacetate. Dev Neurosci 15:320–329
McKenna MC, Stevenson JH, Huan X, Hopkins IB (2000) Differential distribution of the enzymes glutamate dehydrogenase and aspartate aminotransferase in cortical synaptic mitochondria contributes to metabolic compartmentation in cortical synaptic terminals. Neurochem Int 37:229–241
McKenna MC (2007) The glutamate–glutamine cycle is not stoichiometric: fates of glutamate in brain. J Neurosci Res 85:3347–3358
Altschuler RA, Neises GR, Harmison GG, Wenthold RJ, Fex J (1981) Immunocytochemical localization of aspartate aminotransferase immunoreactivity in cochlear nucleus of the guinea pig. Proc Natl Acad Sci USA 78:6553–6657
Altschuler RA, Mosinger JL, Harmison GG, Parakkal MH, Wenthold RJ (1982) Aspartate aminotransferase-like immunoreactivity as a marker for aspartate/glutamate in guinea pig photoreceptors. Nature 298:657–659
Kam K, Nicoll R (2007) Excitatory synaptic transmission persists independently of the glutamate–glutamine cycle. J Neurosci 27:9192–9200
Masson J, Darmon M, Conjard A, Chuhma N, Ropert N, Thoby-Brisson M, Foutz AS, Parrot S, Miller GM, Jorisch R, Polan J, Hamon M, Hen R, Rayport S (2006) Mice lacking brain/kidney phosphate-activated glutaminase have impaired glutamatergic synaptic transmission, altered breathing, disorganized goal-directed behavior and die shortly after birth. J Neurosci 26:4660–4671
Carlson MD, Kish PE, Ueda T (1989) Glutamate uptake into synaptic vesicles: competitive inhibition by bromocriptine. J Neurochem 53:1889–1994
Winter HC, Ueda T (1993) Glutamate uptake system in the presynapric vesicle: glutamic acid analogs as inhibitors and alternative substrates. Neurochem Res 18:79–85
Roseth S, Fykse EM, Fonnum F (1995) Uptake of l-glutamate into rat brain synaptic vesicles: effect of inhibitors that bind specifically to the glutamate transporter. J Neurochem 65:96–103
Ozkan ED, Lee FS, Ueda T (1997) A protein factor that inhibits ATP-dependent glutamate and gamma-aminobutyric acid accumulation into synaptic vesicles: purification and initial characterization. Proc Natl Acad Sci USA 94:4137–4142
Roseth S, Fykse EM, Fonnum F (1998) Uptake of l-glutamate into synaptic vesicles: competitive inhibition by dyes with biphenyl and amino and sulphonic acid substituted naphthyl groups. Biochem Pharmacol 56:1243–1249
Fonnum F, Fykse EM, Roseth S (1998) Uptake of glutamate into synaptic vesicles. Prog Brain Res 116:87–101
Bartlett RD, Esslinger CS, Thompson CM, Bridges RJ (1998) Substituted quinolines as inhibitors of l-glutamate transport into synaptic vesicles. Neuropharmacology 37:839–846
Tamura Y, Ozkan ED, Bole DG, Ueda T (2001) IPF, a vesicular uptake inhibitory protein factor, can reduce the Ca2+-dependent, evoked release of glutamate, GABA and serotonin. J Neurochem 76:1153–1164
Ogita K, Hirata K, Bole DG, Yoshida S, Tamura Y, Leckenby AM, Ueda T (2001) Inhibition of vesicular glutamate storage and exocytotic release by Rose Bengal. J Neurochem 77:34–42
Carrigan CN, Bartlett RD, Esslinger CS, Cybulski KA, Tongcharoensirikul P, Bridges RJ, Thompson CM (2002) Synthesis and in vitro pharmacology of substituted quinoline-2,4-dicarboxylic acids as inhibitors of vesicular glutamate transport. J Med Chem 45:2260–2276
Bole DG, Ueda T (2005) Inhibition of vesicular uptake by Rose Bengal-related compounds: structure activity relationship. Neurochem Res 30:363–369
Thompson CM, Davis E, Carrigan CN, Cox HD, Bridges RJ, Gerdes JM (2005) Inhibitors of the glutamate vesicular transporter (VGLUT). Curr Med Chem 12:2041–2056
Patel SA, Nagy JO, Bolstad ED, Gerdes JM, Thompson CM (2007) Tetrapeptide inhibitors of the glutamate vesicular transporter (VGLUT). Bioorg Med Chem Lett 17:5125–5128
Winter HC, Ueda T (2008) The glutamate uptake system in presynaptic vesicles: further characterization of structural requirements for inhibitors and substrates. Neurochem Res 33:223–231
Pietrancosta N, Kessler A, Favre-Besse FC, Triballeau N, Quentin T, Giros B, El Mestikawy S, Acher FC (2010) Rose Bengal analogs and vesicular glutamate transporters (VGLUTs). Bioorg Med Chem 18:6922–6933
Tamura Y, Ogita K, Ueda T (2014) A new VGLUT-specific potent inhibitor: pharmacophore of brilliant yellow. Neurochem Res 39:117–128
Neale SA, Copeland CS, Uebele VN, Thomson FJ, Salt TE (2013) Modulation of hippocampal synaptic transmission by the kynurenine pathway member xanthurenic acid and other VGLUT inhibitors. Neuropsychopharmacology 38:1060–1067
Neale SA, Copeland CS, Salt TE (2014) Effect of VGLUT inhibitors on glutamatergic synaptic transmission in the rodent hippocampus and prefrontal cortex. Neurochem Int 73:159–165
Reis M, Farage M, Wolosker H (2000) Chloride-dependent inhibition of vesicular glutamate uptake by alpha-keto acids accumulated in maple syrup urine disease. Biochim Biophys Acta 1475:114–118
Di Cosmo A, Nardi G, Di Cristo C, De Santis A, Messenger JB (1999) Localization of l-glutamate and glutamate-like receptors at the squid giant synapse. Brain Res 839:213–220
Kawagoe R, Onodera K, Takeuchi A (1984) The uptake and release of glutamate at the crayfish neuromuscular junction. J Physiol 354:69–78
Katz B, Miledi R (1965) The effect of calcium on acetylcholine release from motor nerve terminals. Proc R Soc Lond B Biol Sci 161:496–503
Katz B, Miledi R (1967) The timing of calcium action during neuromuscular transmission. J Physiol 189:535–544
Katz B, Miledi R (1967) A study of synaptic transmission in the absence of nerve impulses. J Physiol 192:407–436
Katz B, Miledi R (1970) Further study of the role of calcium in synaptic transmission. J Physiol 207:789–801
Llinas R, Nicholson C (1975) Calcium role in depolarization-secretion coupling: and aequorin study in squid giant synapse. Proc Natl Acad Sci USA 72:187–190
Llinas R, Steinberg IZ, Walton K (1976) Presynaptic calcium currents and their relation to synaptic transmission: voltage clamp study in squid giant synapse and theoretical model for the calcium gate. Proc Natl Acad Sci USA 73:2918–2922
Nowycky MC, Fox AP, Tsien RW (1985) Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature 316:440–443
Fox AP, Nowycky MC, Tsien RW (1987) Kinetic and pharmacological properties distinguishing three types of calcium currents in chick sensory neurones. J Physiol 394:149–172
Hirning LD, Fox AP, McCleskey EW, Olivera BM, Thayer SA, Miller RJ, Tsien RW (1988) Dominant role of N-type Ca2+ channels in evoked release of norepinephrine from sympathetic neurons. Science 239:57–61
Catterall WA, Few AP (2008) Calcium channel regulation and presynaptic plasticity. Neuron 59:882–901
Luebke JI, Dunlap K, Turner TJ (1993) Multiple calcium channel types control glutamatergic synaptic transmission in the hippocampus. Neuron 11:895–902
Wheeler DB, Randall A, Tsien RW (1994) Roles of N-type and Q-type Ca2+ channels in supporting hippocampal synaptic transmission. Science 264:107–111
Charlton MP, Augustine GJ (1990) Classification of presynaptic calcium channels at the squid giant synapse: neither T-, L- nor N-type. Brain Res 525:133–139
Araque A, Clarac F, Buno W (1994) P-type Ca2 + channels mediate excitatory and inhibitory synaptic transmitter release in crayfish muscle. Proc Natl Acad Sci USA 91:4224–4228
Quastel DMJ, Hackett JT, Cooke JD (1971) Calcium: is it required for transmitter secretion? Science 172:1034–1036
Brosius DC, Hackett JT, Tuttle JB (1992) Ca(2 +)-independent and Ca(2 +)-dependent stimulation of quantal neurosecretion in avian ciliary ganglion neurons. J Neurophysiol 68:1229–1234
Sudhof TC (2013) Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron 80:675–690
Geppert M, Goda Y, Hammer RE, Li C, Rosahl TW, Stevens CF, Sudhof TC (1994) Synaptotagmin I: a major Ca2 + sensor for transmitter release at a central synapse. Cell 79:717–727
Fernandez-Chacon R, Konigstorfer A, Gerber SH, Garcia J, Matos MF, Stevens CF, Brose N, Rizo J, Rosenmund C, Sudhof TC (2001) Synaptotagmin I functions as a calcium regulator of release probability. Nature 410:41–49
Sudhof TC, Rothman JE (2009) Membrane fusion: grappling with SNARE and SM proteins. Science 323:474–477
Sudhof TC (2013) A molecular machine for neurotransmitter release: synaptotagmin and beyond. Nat Med 19:1227–1231
Sudhof TC (2013) Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron 89:675–690
Greengard P, Valtorta F, Czernik AJ, Benfenati F (1993) Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259:780–785
Llinas R, McGuinness TL, Leonard CS, Sugimori M, Greengard P (1985) Intraterminal injection of Synapsin I or calcium/calmodulin-dependent protein kinase II alters neurotransmitter release at the squid giant synapse. Proc Natl Acad Sci USA 82:3035–3039
Hackett JT, Cochran SL, Greenfield LJ Jr, Brosius DC, Ueda T (1990) Synapsin I injected presynaptically into goldfish mauthner axons reduces quantal synaptic transmission. J Neurophysiol 63:701–706
Tokumaru H, Umayahara K, Pellegrini LL, Ishizuka T, Saisu H, Betz H, Augustine GJ, Abe T (2001) SNARE complex oligomerization by synaphin/complexin is essential for synaptic vesicle exocytosis. Cell 104:421–432
Steyer JA, Horstmann H, Almers W (1997) Transport, docking and exocytosis of single secretory granules in live chromaffin cells. Nature 388:474–478
Zenisek D, Steyer JA, Feldman ME, Almers W (2002) A membrane marker leaves synaptic vesicles in milliseconds after exocytosis in retinal bipolar cells. Neuron 35:1085–1097
Mallart A, Martin AR (1967) An analysis of facilitation of transmitter release at the neuromuscular junction of the frog. J Physiol 193:679–694
Charlton MP, Bittner GD (1978) Facilitation of transmitter release at squid synapses. J Gen Physiol 72:471–486
Dudel J, Kuffler SW (1981) Mechanism of facilitation at the crayfish neuromuscular junction. J Physiol 155:530–542
Wernig A (1972) Changes in statistical parameters during facilitation at the crayfish neuromuscular junction. J Physiol 226:751–759
Linder TM (1974) The accumulative properties of facilitation at crayfish neuromuscular synapses. J Physiol 238:223–234
Herman MA, Ackermann F, Trimbuch T, Rosenmund C (2014) Vesicular glutamate transporter expression level affects synaptic vesicle release probability at hippocampal synapses in culture. J Neurosci 34:11781–11791
Worden MK, Bykhovskaia M, Hackett JT (1997) Facilitation at the lobster neuromuscular junction: a stimulus-dependent mobilization model. J Neurophysiol 78:417–428
Bykhovskaia M, Hackett JT, Worden MK (1999) Asynchrony of quantal events in evoked multiquantal responses indicates presynaptic quantal interaction. J Neurophysiol 81:2234–2242
Katz B, Miledi R (1968) Further studies on the role of calcium in synaptic transmission. J Physiol 207:789–801
Kamiya H, Zucker RS (1994) Residual Ca2+ and short-term synaptic plasticity. Nature 371:603–606
Magleby KL (1979) Facilitation, augmentation, and potentiation of transmitter release. Prog Brain Res 49:175–182
Dixon D, Atwood HL (1989) Conjoint action of phosphatidylinositol and adenylate cyclase systems in serotonin-induced facilitation at the crayfish neuromuscular junction. J Neurophysiol 62:1251–1259
Bliss TV, Lomo T (1973) Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 232:331–356
Granger AJ, Nicoll RA (2014) Expression mechanisms underlying long-term potentiation: a postsynaptic view, 10 years on. Philos Trans R Soc Lond B Biol Sci 369:20130136
Hamilton NB, Attwell D (2010) Do astrocytes really exocytose neurotransmitters? Nat Rev Neurosci 11:227–238
Author information
Authors and Affiliations
Corresponding author
Additional information
Special Issue: In Honor of Dr. Gerald Dienel.
Rights and permissions
About this article
Cite this article
Hackett, J.T., Ueda, T. Glutamate Release. Neurochem Res 40, 2443–2460 (2015). https://doi.org/10.1007/s11064-015-1622-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-015-1622-1